INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 418m ago
House PTR17m ago
SEC 13F17m ago
Robinhood Chain17m ago

Results

8,832 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
33
BK
Banks Margaret KatherineDirector
HALHALLIBURTON CO
Open-market sale
SELL$89K
2,600 sh
Jan 26, 2026Jan 27, 2026
Page 166 of 221
← PrevNext →
traded Jan 26, 2026
+1d
SEC Form 4

Evidence

32
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Open-market sale
SELL$423K
89.1K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

30
WF
Walsh John FCEO-The Americas
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$718K
2,600 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

30
KJ
Kuffner JamesCHIEF TECHNOLOGY OFFICER
SYMSymbotic Inc.
Open-market sale
SELL$63K
1,048 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

62
RG
Rooney Robert GeraldDirector
NONENONETCW Private Asset Income Fund
Open-market purchase
BUY$281K
28.1K sh
Nov 10, 2025Jan 26, 2026
traded Nov 10, 2025
+77dSEC Form 4

Evidence

59
RG
Rooney Robert GeraldDirector
NONENONETCW Private Asset Income Fund
Open-market purchase
BUY$113K
11.3K sh
Nov 10, 2025Jan 26, 2026
traded Nov 10, 2025
+77dSEC Form 4

Evidence

41
CL
Cheng LawrenceDirector
GMEGameStop Corp.
Open-market purchase
BUY$114K
5,000 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$1.00M
9,525 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$1.99M
5,128 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$1.00M
9,525 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$3.32M
8,500 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$2.81M
7,200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$2.00M
19.1K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

33
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale
SELL$777K
1,577 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

33
TA
Tpg Gp A, Llc10% Owner
SIONSionna Therapeutics, Inc.
Open-market sale
SELL$10.00M
250.0K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
WA
Wilson Kelli AnnEVP Chief Banking Officer
HFWAHERITAGE FINANCIAL CORP /WA/
Open-market sale
SELL$50K
1,900 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$911K
2,300 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$500K
4,765 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$511K
1,295 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$864K
2,200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

30
TR
Taub RebeccaDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale
SELL$319K
647 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

70
NR
Nielson Brandon R.Director
NANAKeystone Private Income Fund
Open-market purchase
BUY$2.00M
20.3K sh
Jan 1, 2026Jan 23, 2026
traded Jan 1, 2026
+22dSEC Form 4

Evidence

63
EJ
Earl JohnPresident
NANAKeystone Private Income Fund
Open-market purchase
BUY$1000K
10.1K sh
Jan 1, 2026Jan 23, 2026
traded Jan 1, 2026
+22dSEC Form 4

Evidence

61
AJ
Agarwal A.J.Director, Co-President
NONENONEBlackstone Real Estate Income Trust, Inc.
Open-market purchase
BUY$4.00M
287.3K sh
Dec 1, 2025Jan 23, 2026
traded Dec 1, 2025
+53dSEC Form 4

Evidence

58
AB
Allen BradTreasurer
NANAKeystone Private Income Fund
Open-market purchase
BUY$1.00M
10.1K sh
Jan 1, 2026Jan 23, 2026
traded Jan 1, 2026
+22dSEC Form 4

Evidence

46
KR
Kushel J. RichardSenior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$22.50M
20.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

45
CM
Carr James McgregorExecutive Vice Pres.
CMACOMERICA INC
Open-market sale
SELL$981K
10.0K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

45
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Open-market sale
SELL$863K
8,798 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.03M
10.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$4.93M
52.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$8.12M
87.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

42
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$86K
926 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

40
WG
Woodruff Ronald GreerEVP Safety, ESG, Maintenance
JBHTHUNT J B TRANSPORT SERVICES INC
Open-market sale
SELL$288K
1,391 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

38
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$170K
1,822 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

38
RP
Radovich PeterPRESIDENT AND COO
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$222K
2,382 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.75M
19.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

36
GV
Gadde VijayaDirector
PLPlanet Labs PBC
Open-market sale
SELL$535K
20.0K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.54M
27.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.99M
33.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.02M
23.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence